论文信息 - Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies - 字舞流文

Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies

Scott E. Smith | N. Bartlett | O. O’Connor | A. Forero-Torres | M. Fanale | Robert Chen | D. Huebner | R. Olshefski | J. Matous | A. Gopal | L. Grove | R. Berryman | Pamela Levine | Robert Chen